NewsRamp Editorial Team
NewsRamp
@newsramp
NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
3808 articles
Articles
FAQ: Medication vs. Procedure for High-Risk Atrial Fibrillation Patients
What is the main finding of the CLOSURE-AF study? The study found that standard medical care, including blood thinners when eligible, was better than a catheter-based left atrial appendage closure procedure for preventing stroke, blood clots, cardiovascular death, or major bleeding in high-risk atrial fibrillation patients....
November 8, 2025Read more
FAQ: One-Month vs. Year-Long Clot Prevention Therapy After Stent Placement in AFib Patients
What is the main finding of this research? A one-month course of dual clot-preventing therapy followed by single medication therapy was as effective as one year of continuous dual therapy for preventing stroke, heart attack, and death in adults with atrial fibrillation who received a coronary stent. Why is this research sig...
November 8, 2025Read more
FAQ: New Oral Cholesterol Medication Enlicitide - Key Information
What is the main topic of this research? The research focuses on enlicitide, a new daily oral medication that can lower LDL (bad) cholesterol by up to 60%, potentially offering a more convenient alternative to injectable PCSK9 inhibitors for high-risk patients. Who could benefit from this new medication? People who have exp...
November 8, 2025Read more
FAQ: PCSK9 Inhibitor Evolocumab Reduces Cardiovascular Events in High-Risk Patients Without Prior Heart Attack or Stroke
What is the main finding of the VESALIUS-CV trial? The trial found that adding evolocumab, a PCSK9 inhibitor, to high-intensity cholesterol-lowering regimens reduced the risk of coronary heart disease death, heart attack, or ischemic stroke by 25% in patients with atherosclerotic cardiovascular disease or diabetes who had n...
November 8, 2025Read more
FAQ: CRISPR Gene-Editing Therapy for Cholesterol and Triglyceride Reduction
What is CTX310 and what does it do? CTX310 is an investigational CRISPR-Cas9 gene-editing therapy delivered as a one-time infusion that targets and turns off the ANGPTL3 gene in the liver, resulting in significant reductions in LDL cholesterol and triglycerides. How effective was this therapy in the trial? The therapy reduc...
November 8, 2025Read more
FAQ: New Medication DR10624 for Severe Hypertriglyceridemia
What is DR10624 and what does it treat? DR10624 is a first-of-its-kind investigational medication designed to treat severe hypertriglyceridemia (triglyceride levels between 500-2,000 mg/dL), a condition that increases risk of cardiovascular disease, pancreatitis, and liver damage. How effective was DR10624 in the clinical t...
November 8, 2025Read more
FAQ: Fifth Annual Sickle Cell Caregiver Summit 2025
What is the Sickle Cell Caregiver Summit and what is its main purpose? The Sickle Cell Caregiver Summit is an annual virtual conference that brings together caregivers, patients, healthcare providers, and advocates for four days of education, empowerment, and inspiration, focusing on balancing mental wellness, advocacy, and...
November 8, 2025Read more
FAQ: Airport Sanitation and Safety Oversight Failures White Paper
What is the main topic of the white paper published by New York Airport News? The white paper titled 'Systemic Sanitation and Environmental Failures at U.S. Airports' reveals critical lapses in environmental and sanitation oversight across major American airports and how these failures may contribute to aviation safety risk...
November 8, 2025Read more
FAQ: Yao Wen's Role as Production Designer for Scroll&Swoon's 'Carole's Regrets'
What is the main announcement in this content? Scroll&Swoon has appointed Yao Wen as production designer for their upcoming vertical-format series 'Carole's Regrets,' where she will lead the visual design and aesthetic direction. Who is Yao Wen and what is her role? Yao Wen is the production designer for 'Carole's Regrets,'...
November 8, 2025Read more
FAQ: Vedant Dave as Director of Photography for 'The Last Address' Feature Film
What is 'The Last Address' about? The Last Address is a feature film that follows Arjun, a young Indian student searching for his estranged father in America, and explores his unexpected friendship with Mr. Sharma, an elderly immigrant living alone in Los Angeles, capturing themes of migration, belonging, and intergeneratio...
November 8, 2025Read more
FAQ: Cymatics Digital's Short Film 'My Life in LA' and Producer Yang Qian's Role
What is the main announcement in this press release? Cymatics Digital has announced that acclaimed producer Yang Qian has officially joined as Lead Producer for their upcoming short film project 'My Life in LA,' which is the sixth installment in the company's distinguished slate of projects. Who is Yang Qian and what is her...
November 8, 2025Read more
Klaiyi Hair 2025 Black Friday Pre-Sale Event FAQ
What is the Klaiyi Hair 2025 Black Friday Pre-Sale event? It's a two-phase sale event offering exceptional savings and exclusive offers on Klaiyi Hair's premium human hair products, including wigs and hair bundles, running from November 6 through November 20, 2025. When does the Black Friday Pre-Sale take place? The event r...
November 8, 2025Read more
FAQ: Milevista and Operation Smile Partnership for Cleft Care Fundraising
What is the main purpose of the Milevista and Operation Smile partnership? The partnership aims to raise $6.7 million by December 31, 2027, to support Operation Smile's surgical care, comprehensive cleft treatment, and family-focused programs for children worldwide. How will Milevista help raise funds for Operation Smile? M...
November 8, 2025Read more
FAQ: TuneFab's Evolution from Downloader to All-in-One Music Management Hub
What is the main change TuneFab has announced? TuneFab has evolved from being primarily a music downloader into an all-in-one music management hub that provides unified control over music from multiple streaming platforms, including download, organization, and editing capabilities. Why is this update significant for music l...
November 8, 2025Read more
FAQ: TSC's AI Signal Copier - Revolutionizing Automated Trading
What is the TSC AI Signal Copier and what makes it different from conventional trade copiers? The TSC AI Signal Copier is an automated signal copier equipped with powerful AI functionalities that can intelligently interpret and execute trading signals from Telegram channels. Unlike conventional trade copiers, it is designed...
November 8, 2025Read more
SureShotFX Forex Signal Provider FAQ
What is SureShotFX and what does it offer? SureShotFX is a foreign currency signal provider that offers daily trading signals for major, minor, and exotic currency pairs, including specialized XAUUSD signals for gold trading, with real-time notifications delivered through Telegram. Why is SureShotFX considered a reliable ch...
November 8, 2025Read more
Betty Sports AI Sports Prediction Platform FAQ
What is Betty Sports' new platform? Betty Sports has unveiled a groundbreaking AI sports prediction platform that uses artificial intelligence and advanced analytics to provide data-driven insights for sports betting across major sports leagues. Which sports leagues does the platform cover? The platform covers prominent spo...
November 7, 2025Read more
FAQ: Voyageur Pharmaceuticals' Board Expansion with Virginia Alling
What is the main announcement in this content? Voyageur Pharmaceuticals Ltd. has appointed Virginia Alling as an independent director to strengthen its board of directors, subject to regulatory approval. Who is Virginia Alling and what experience does she bring? Virginia Alling is a seasoned financial executive with over 30...
November 7, 2025Read more
FAQ: Catalyst Marketing Agency's New Head of Growth and Five-Year Strategy
What is the main announcement in this content? Catalyst Marketing Agency has appointed Michael Nelson as its new Head of Growth to support the organization's ten-year strategy and drive growth initiatives across all U.S. offices. Who is Michael Nelson and what experience does he bring? Michael Nelson brings over a decade of...
November 7, 2025Read more
FAQ: Oncotelic Therapeutics' Sapu Nano Venture Begins Clinical Trials for Innovative Breast Cancer Therapy
What is the main announcement in this content? Oncotelic Therapeutics' venture Sapu Nano has received approval from Australia's Human Research Ethics Committee to begin enrolling patients in clinical trials for Sapu003, an injectable form of Afinitor (everolimus) for breast cancer treatment. Why is this clinical trial appro...
November 7, 2025Read more
FAQ: Datavault AI's Partnership with Rodney's Comedy Club for VerifyU, Joke Token, and ADIO® Integration
What is the main purpose of Datavault AI's partnership with Rodney's Comedy Club? The partnership aims to transform live comedy into an interactive, data-driven experience by integrating Datavault AI's VerifyU, Joke Token, and ADIO® technologies, making Rodney's the first U.S. venue to issue verifiable digital credentials a...
November 7, 2025Read more